Industry Insights

  1. Building Biopharma Resilience In Developing Gene Therapies 3/21/2024

    Learn about the opportunities and challenges surrounding gene therapies, the importance of collaboration between biopharma startups and academia, difficulties with the talent pipeline, and more.

  2. Genome Editing Using mRNA-Lipid Nanoparticles For CAR T Cell Therapy 11/22/2023

    Gene delivery platforms must support a diversity of genetic engineering strategies for genomic medicine development. Learn how lipid nanoparticles can accelerate development from discovery to scale-up.

  3. 5 Supply Chain Questions Every Drug Company Should Know The Answers To 1/14/2020

    Part 1 of this two-part column raised the point that if you’re not happy with one or more of your suppliers, it may be because you haven’t clearly told them what you want, what your expectations are, and what is important to you. Here in Part 2, we explore five important questions that can serve as a brief checklist to help drug companies both figure out and communicate their expectations to suppliers and understand their suppliers’ expectations.

  4. Improve Process Validation For Dry Granulation, Solid Dosage Form Unit Ops

    Process validation establishes the elasticity and restrictions in manufacturing process controls to deliver upon the specified attributes of the dosage form while preventing undesirable results.

  5. Comparing Vial Container Closure Systems

    Examine a case study where two 20mm vial CCSs were compared using the DeltaCube™ Modeling Platform and experimentally show the link between prediction and real performance.

  6. Here's Why The Life Sciences Struggle To Exploit Process Knowledge 1/2/2025

    Pharma often fails to take full advantage of the vast amounts of data it produces. It could do better with knowledge management embedded as a core business strategy.

  7. "Human Error" Deviations: How You Can Stop Creating (Most Of) Them 10/9/2017

    In the time it takes you to read this article, the industry will generate (conservatively) about 115 new process deviations, and about 65 of them will be misclassified as having something related to “human error” as either the principal causal factor or one of the proximal causal factors.

  8. The Cost Of A Broken Vaccine Cold Chain Part One, Human Cost

    With the advent of flu season, patients swarm to immunization programs throughout the country. Yet, each year, some of those vaccinated succumb to life-threatening seasonal influenza.

  9. Is A Multitherapeutic Contract Research Partner The Best Fit For Your Clinical Trial? 7/7/2021

    You wouldn’t hire a house painter to retouch fine artwork, so why would you contract a jack-of-all-trades research organization to pilot a clinical trial with critical end points that require specific, in-depth expertise?

  10. Physical Properties Tests For The Pharmaceutical Engineer 2/23/2017

    Products packaged for consumer use by the pharma industry go through a battery of tests related to how the user applies the product.